Join
Live feed
·
PRReleasevia Quantisnow
Gilead Sciences Inc. logo
Merck & Company Inc. logo

Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study

ByQuantisnow·Wall Street's wire, on your screen.
GILD· Gilead Sciences Inc.MRK· Merck & Company Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GILD (Gilead Sciences Inc.), MRK (Merck & Company Inc.) and more on Quantisnow.

Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study | Quantisnow